Federal agencies such as the FDA and HHS are working on safety programs to regulate the use of artificial intelligence (AI) in healthcare. Digital health executives provided recommendations for regulators, emphasizing the need to incorporate existing regulations like HIPAA and GDPR, and to label AI-generated content. They also emphasized the importance of setting clear boundaries for data privacy and preventing the creation of silos in healthcare. The executives also stressed the need for transparency and collaboration in developing regulatory guidance for AI in healthcare. Ultimately, they highlighted the importance of ensuring reliability and full disclosure to patients when AI is involved in their care.
Source link
Recommendations to regulators configuring rules on AI use in healthcare
